Overview

Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to compare the efficacy of aripiprazole with placebo in patients with psychosis associated with Alzheimer's dementia.
Phase:
Phase 3
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Collaborator:
Otsuka America Pharmaceutical
Treatments:
Aripiprazole